Phase 5 — Apoptosis, Innate Immunity & Viragenesis Convergence Analysis

Program: PROJECT STRANDSHIFT

Classification: DNA Injury → Innate Immunity → Viral-Mimicry → Cell Fate Mapping Framework

Primary Objective:

To determine the biological thresholds and mechanistic transitions through which DNA injury, genomic instability, RNA dysregulation, and cellular stress activate innate immune sensing pathways, viral-mimicry programs, endogenous retroelements, apoptosis, or tissue degeneration.

1. EXECUTIVE SUMMARY

The Apoptosis–Viragenesis Map establishes a systems-level framework describing how injured cells transition through:

1. DNA damage response
2. Genome instability
3. Cytosolic DNA/RNA sensing
4. Antiviral-state activation
5. Viral mimicry
6. Retroelement activation
7. Cellular adaptation
8. Senescence
9. Apoptosis
10. Tissue degeneration

The framework does not assume that damaged DNA becomes a virus.

Instead, it investigates how DNA injury may trigger biological states that resemble antiviral responses and under what conditions those responses transition into programmed cell death.

2. CENTRAL STRANDSHIFT QUESTION

Core Biological Problem

When does DNA injury result in:

Outcome A

Successful repair and recovery

versus

Outcome B

Persistent innate immune activation

versus

Outcome C

Apoptotic execution

3. APOPTOSIS–VIRAGENESIS CONTINUUM

Stage 0 — Homeostasis

Characteristics

• Normal DNA integrity
• Functional repair pathways
• Controlled immune surveillance
• Stable chromatin architecture

Cell State

Healthy

Stage 1 — DNA Injury Initiation

Trigger Events

• Oxidative stress
• Replication stress
• Double-strand breaks
• Repeat expansion instability
• Mitochondrial ROS production

Primary Markers

• γH2AX
• 53BP1
• ATM
• ATR

Cell State

Repairable Injury

Stage 2 — DNA Damage Response Activation

Activated Systems

• ATM
• ATR
• CHK1
• CHK2
• PARP1
• BRCA1
• BRCA2

Primary Goal

Genome preservation

Possible Outcomes

• Successful repair
• Persistent damage

Cell State

Adaptive Response

Stage 3 — Genomic Instability State

Characteristics

• Unresolved DNA lesions
• Repeat expansion
• Chromosomal instability
• Micronuclei formation

Primary Markers

• Micronuclei
• Copy-number variation
• Structural rearrangements

Cell State

Genome-Stress State

4. VIRAGENESIS TRANSITION NODE

Critical Transition Point

DNA injury becomes capable of activating innate immune sensing.

This is the first Viragenesis Threshold.

Triggers

Cytosolic DNA Leakage

Micronuclear Rupture

Mitochondrial DNA Release

dsRNA Accumulation

Retroelement Expression

5. VIRAGENESIS NODE I

Cytosolic DNA Sensing

Sensor

cGAS

↓

STING

↓

TBK1

↓

IRF3

↓

Interferon Production

Outputs

• IFN-α
• IFN-β
• ISG activation

Classification

DNA Injury–Induced Antiviral State

6. VIRAGENESIS NODE II

RNA Sensing Activation

Sensors

RIG-I

MDA5

TLR3

Triggers

• dsRNA accumulation
• aberrant repeat RNA
• retroelement transcripts

Outputs

• Interferon signaling
• antiviral-state activation

Classification

RNA Injury–Associated Viral Mimicry

7. VIRAGENESIS NODE III

Endogenous Retroelement Activation

Elements

• HERV-K
• HERV-W
• LINE-1

Triggers

• Epigenetic derepression
• DNA injury
• chronic inflammation

Outputs

• Retroviral-like transcripts
• innate immune activation

Classification

Endogenous Viragenesis

8. ADAPTATION vs DEGENERATION CHECKPOINT

Decision Point

Can the cell successfully resolve injury?

If YES

Recovery Pathway

• Repair
• Survival
• Homeostasis restoration

If NO

Proceed to:

• chronic inflammation
• senescence
• apoptosis

9. APOPTOSIS ACTIVATION THRESHOLD

Trigger Conditions

Severe DNA Damage

Persistent cGAS-STING Activation

Mitochondrial Failure

Proteotoxic Stress

Chronic Interferon Signaling

Master Regulators

TP53

BAX

BAK

CASP9

CASP3

CASP7

10. APOPTOSIS EXECUTION CASCADE

DNA Injury

↓

p53 Activation

↓

Mitochondrial Dysfunction

↓

Cytochrome C Release

↓

APAF1 Activation

↓

Caspase-9

↓

Caspase-3

↓

Apoptosis

11. SENESCENCE ALTERNATIVE PATHWAY

Characteristics

Cell survives but remains dysfunctional.

Biomarkers

• p16INK4A
• p21
• SASP

Consequences

• chronic inflammation
• immune activation
• tissue dysfunction

12. STRANDSHIFT APOPTOSIS–VIRAGENESIS TIERS

Tier I

DNA Injury

Markers

• γH2AX
• 53BP1

Tier II

DNA Damage Response

Markers

• ATM
• ATR
• PARP1

Tier III

Genomic Instability

Markers

• micronuclei
• CNVs

Tier IV

Innate Immune Sensing

Markers

• cGAS
• STING
• TBK1

Tier V

Antiviral-State Activation

Markers

• IFN-I
• ISGs

Tier VI

Viral Mimicry

Markers

• OAS1
• MX1
• IFIT family

Tier VII

Retroelement Activation

Markers

• HERV-K
• HERV-W
• LINE-1

Tier VIII

Chronic Inflammation

Markers

• IL-6
• TNF-α
• IL-1β

Tier IX

Apoptotic Commitment

Markers

• TP53
• BAX
• CASP9

Tier X

Cell Death

Markers

• CASP3
• CASP7
• TUNEL

13. HTT-SPECIFIC APOPTOSIS–VIRAGENESIS MODEL

HTT Expansion

↓

Somatic Expansion

↓

DNA Repair Stress

↓

DNA Damage Accumulation

↓

Micronuclei Formation

↓

cGAS-STING Activation

↓

Interferon Signaling

↓

Neuroimmune Activation

↓

Mitochondrial Dysfunction

↓

Apoptotic Commitment

↓

Neuronal Death

↓

Clinical Progression

14. REQUIRED BIOMARKER PANELS

DNA Injury Panel

• γH2AX
• 53BP1
• ATM
• ATR

Viragenesis Panel

• cGAS
• STING
• TBK1
• IRF3

Viral Mimicry Panel

• IFN-α
• IFN-β
• OAS1
• MX1
• IFIT1

Retroelement Panel

• HERV-K
• HERV-W
• LINE-1

Apoptosis Panel

• TP53
• BAX
• BCL2
• CASP3
• CASP7
• CASP9
• TUNEL

15. COMPOSITE INDICES

DNA Injury Burden Index (DIBI)

Measures:

• DNA breaks
• repair stress
• genomic instability

Viragenesis Activation Index (VAI)

Measures:

• cGAS-STING activity
• interferon output
• ISG expression

Viral Mimicry Burden Score (VMBS)

Measures:

• antiviral-state intensity
• dsRNA sensing
• HERV activation

Apoptotic Commitment Index (ACI)

Measures:

• TP53 activation
• caspase burden
• mitochondrial apoptosis

STRANDSHIFT Cell Fate Index (SCFI)

Measures:

Probability of:

• recovery
• senescence
• apoptosis

16. STRATEGIC RESEARCH QUESTIONS

1. What DNA injury threshold activates cGAS-STING signaling?
2. Which HTT-associated lesions produce the strongest antiviral-state signatures?
3. Does somatic expansion correlate with Viragenesis Activation Index scores?
4. Are HERV activation patterns linked to disease stage?
5. Can chronic viral-mimicry signaling predict neuronal loss?
6. Which biomarkers best distinguish repair, senescence, and apoptosis trajectories?
7. Can therapeutic suppression of maladaptive innate immune signaling reduce neurodegeneration?

17. CONCLUSION

The Apoptosis–Viragenesis Map establishes the mechanistic bridge between DNA injury and cell fate determination. Within PROJECT STRANDSHIFT, DNA damage is conceptualized as a trigger for innate immune sensing, antiviral-state activation, viral-mimicry biology, and retroelement activation. Persistent activation of these pathways may contribute to chronic neuroinflammation, mitochondrial dysfunction, and apoptotic commitment.

The central research objective is to identify the transition thresholds at which adaptive genome repair fails and maladaptive immune activation or cell death becomes the dominant biological outcome.